KEGG: ppd:Ppro_1226
STRING: 338966.Ppro_1226
Cobalt transport protein CbiM 1 (cbim1) is a membrane protein that functions as part of an energy-coupling factor (ECF) transport system in Pelobacter propionicus. This protein specifically serves as a substrate-capture component responsible for binding cobalt ions before their transport across the cell membrane. The protein plays an essential role in cobalt homeostasis, which is critical for various cellular processes including vitamin B12 (cobalamin) biosynthesis and enzymatic functions requiring cobalt as a cofactor. The full-length protein consists of 226 amino acids with a molecular structure optimized for membrane integration and ion binding .
Recombinant cbim1 protein requires specific storage and handling conditions to maintain its structural integrity and functional properties. The protein is typically supplied as a lyophilized powder and should be stored at -20°C to -80°C upon receipt. Working aliquots can be maintained at 4°C for up to one week, but repeated freeze-thaw cycles should be avoided as they can compromise protein stability.
For reconstitution, the protein should be dissolved in deionized sterile water to a concentration of 0.1-1.0 mg/mL. Addition of glycerol to a final concentration of 5-50% is recommended for long-term storage. The reconstituted protein is typically stable in Tris/PBS-based buffer (pH 8.0) containing 6% trehalose. Prior to opening, vials should be briefly centrifuged to ensure all content is collected at the bottom .
The structure of cbim1 from Pelobacter propionicus shares conserved domains with other bacterial cobalt transporters while exhibiting distinct features that impact its metal ion specificity. Analysis of its amino acid sequence reveals multiple transmembrane domains and metal-binding motifs characteristic of the CbiM family of transporters.
The protein contains key structural elements including:
| Structural Element | Amino Acid Position | Predicted Function |
|---|---|---|
| Transmembrane helix 1 | 23-45 | Membrane anchoring and pore formation |
| Transmembrane helix 2 | 72-94 | Channel structure |
| Transmembrane helix 3 | 110-132 | Ion selectivity |
| Transmembrane helix 4 | 156-178 | Conformational changes during transport |
| Metal-binding domain | 48-67 | Cobalt coordination |
Unlike zinc or iron transporters, the metal-binding domain of cbim1 contains specific residues optimized for cobalt coordination geometry. These structural features confer selectivity for cobalt over other divalent metals, though some cross-reactivity with nickel ions can occur under certain conditions. Understanding these structural determinants is crucial for research involving metal transport mechanisms and the development of selective inhibitors .
Cobalt transport protein CbiM 1 functions as part of a multi-component Energy-Coupling Factor (ECF) transport complex. Based on studies of homologous systems, cbim1 likely interacts with several protein partners to form a functional transport apparatus:
CbiQ - A transmembrane component that forms the translocation channel
CbiO - An ATPase subunit that provides energy through ATP hydrolysis
CbiN - A small membrane protein that enhances transport efficiency
These interactions form a quaternary complex structure where cbim1 serves as the substrate-binding protein that captures cobalt ions from the extracellular environment. The protein-protein interactions occur primarily through specific transmembrane domains and cytoplasmic loops. Research investigating these interactions typically employs co-immunoprecipitation, bacterial two-hybrid systems, or structural biology approaches such as cryo-electron microscopy.
Understanding these interaction networks is essential for comprehending the complete mechanism of cobalt transport and its regulation in Pelobacter propionicus and related bacterial species .
While the native cbim1 protein may undergo various post-translational modifications (PTMs) in Pelobacter propionicus, recombinant cbim1 expressed in E. coli systems typically lacks many of these modifications due to differences in cellular machinery. This discrepancy can significantly impact protein function and experimental outcomes.
Potential PTMs that may affect cbim1 function include:
| Post-translational Modification | Potential Effect on Function |
|---|---|
| Phosphorylation | May regulate transport activity and protein-protein interactions |
| Glycosylation | Rare in bacterial proteins but could affect stability if present |
| Lipid modification | May enhance membrane association and orientation |
| Disulfide bond formation | Could stabilize tertiary structure and metal-binding capacity |
Research comparing native and recombinant forms suggests that the absence of specific PTMs in recombinant cbim1 may result in altered cobalt binding affinity or transport kinetics. For studies requiring native-like function, expression systems that can perform relevant PTMs should be considered. Alternatively, in vitro modification approaches may be employed to introduce specific PTMs to the recombinant protein .
Optimizing expression of recombinant cbim1 in E. coli requires careful consideration of several parameters to maximize yield while maintaining proper protein folding and function. The following protocol has been established as effective for cbim1 expression:
Expression vector selection: pET series vectors with T7 promoter provide strong, inducible expression
E. coli strain: BL21(DE3) or Rosetta(DE3) for enhanced expression of membrane proteins
Culture conditions:
Media: LB supplemented with 0.5% glucose and appropriate antibiotics
Temperature: Initial growth at 37°C until OD600 reaches 0.6-0.8
Induction: IPTG at 0.5 mM final concentration
Post-induction: Temperature reduction to 18-20°C for 16-18 hours
Cell harvest and lysis:
Centrifugation at 5000×g for 15 minutes at 4°C
Resuspension in lysis buffer containing 50 mM Tris-HCl pH 8.0, 150 mM NaCl, 1% DDM (n-Dodecyl β-D-maltoside), and protease inhibitors
Sonication or pressure-based lysis followed by centrifugation at 20,000×g for 30 minutes
This protocol typically yields 2-5 mg of purified protein per liter of culture. Modifications may be necessary based on specific research requirements and equipment availability .
Purification of His-tagged recombinant cbim1 can be achieved through a multi-step process optimized for membrane proteins:
Resin: Ni-NTA or TALON
Binding buffer: 50 mM Tris-HCl pH 8.0, 300 mM NaCl, 0.1% DDM, 10 mM imidazole
Wash buffer: Same as binding buffer with 20-30 mM imidazole
Elution buffer: Same as binding buffer with 250-300 mM imidazole
Flow rate: 0.5-1 mL/min for optimal binding
Column: Superdex 200 or equivalent
Buffer: 20 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.05% DDM
Flow rate: 0.3-0.5 mL/min
For samples requiring additional purification
Column: Q Sepharose for anion exchange
Buffer A: 20 mM Tris-HCl pH 8.0, 0.05% DDM
Buffer B: Same as Buffer A with 1 M NaCl
Gradient: 0-50% Buffer B over 20 column volumes
Final purity can be assessed by SDS-PAGE (expected >90% purity) and Western blotting using anti-His antibodies. Typical yield from this purification protocol is 1-3 mg of pure protein per liter of bacterial culture. The purified protein should be immediately used for experiments or stored as described in the storage recommendations .
Multiple analytical techniques should be employed to comprehensively assess the structural integrity and functional status of purified recombinant cbim1:
Circular Dichroism (CD) Spectroscopy
Far-UV (190-260 nm): Secondary structure assessment
Near-UV (250-320 nm): Tertiary structure fingerprinting
Expected results: Primarily α-helical content with characteristic minima at 208 nm and 222 nm
Differential Scanning Calorimetry (DSC)
Temperature range: 20-90°C
Scan rate: 1°C/min
Buffer: 20 mM phosphate, pH 7.4
Parameter to determine: Thermal transition midpoint (Tm)
Dynamic Light Scattering (DLS)
Concentration range: 0.5-1 mg/mL
Expected hydrodynamic radius: 3-5 nm (monomer)
Metal Binding Assay
Isothermal Titration Calorimetry (ITC) with CoCl2
Expected binding affinity (Kd): 0.1-10 μM range
Stoichiometry: Typically 1:1 protein:cobalt ratio
Reconstitution into Liposomes
Lipid composition: POPC:POPE (7:3)
Protein:lipid ratio: 1:100 to 1:1000 (w/w)
Transport assay using radioactive 57Co or fluorescent cobalt indicators
These analytical approaches provide complementary information about protein structure, stability, and function. Discrepancies between expected and observed results may indicate misfolding, aggregation, or loss of functional integrity during expression or purification processes .
Investigating the functional significance of specific amino acid residues in cbim1 requires a systematic approach combining site-directed mutagenesis with functional assays:
In silico analysis
Use homology modeling based on related transporters
Perform sequence alignment with other CbiM proteins
Identify conserved residues in metal-binding regions
Prioritize histidine, cysteine, aspartate, and glutamate residues for mutation
Site-directed mutagenesis
Generate single amino acid substitutions (typically to alanine)
Focus on residues in predicted transmembrane domains and metal-binding sites
Create a library of mutants expressing the following substitutions:
Conservative substitutions (maintaining charge/polarity)
Non-conservative substitutions (altering charge/polarity)
Deletion mutants for critical regions
Expression and purification
Express wild-type and mutant proteins under identical conditions
Purify using standard protocols (IMAC followed by SEC)
Verify protein integrity by SDS-PAGE and Western blotting
Functional characterization
Metal binding assays:
ITC to determine binding affinity constants (Kd)
Fluorescence spectroscopy with metal-sensitive probes
Transport assays:
Proteoliposome-based cobalt uptake assays
Whole-cell cobalt accumulation measurements
Structural analysis
CD spectroscopy to confirm proper folding
Limited proteolysis to assess conformational changes
X-ray crystallography or cryo-EM for selected mutants
Analysis should focus on correlating changes in metal binding or transport activity with specific amino acid substitutions. This approach can identify critical residues involved in cobalt coordination, conformational changes during transport, or protein-protein interactions within the transporter complex .
Investigating protein-protein interactions within the cobalt transport system requires multiple complementary approaches:
Bacterial two-hybrid system
Construct fusions of cbim1 and potential partners to split reporter proteins
Screen for interactions based on reporter activation
Quantify interaction strength through reporter activity levels
Co-expression studies
Create operons expressing multiple components of the transport system
Assess functional complementation in transport-deficient strains
Measure transport activity as a readout of successful complex formation
Co-immunoprecipitation (Co-IP)
Express epitope-tagged versions of cbim1 and partner proteins
Use antibodies against tags to pull down protein complexes
Identify interacting partners by Western blotting or mass spectrometry
Cross-linking coupled with mass spectrometry
Use chemical cross-linkers of varying lengths to stabilize transient interactions
Digest cross-linked complexes and analyze by LC-MS/MS
Identify cross-linked peptides to map interaction interfaces
| Cross-linking Agent | Spacer Length | Reactive Groups | Application |
|---|---|---|---|
| DSS | 11.4 Å | Amine-amine | General protein-protein interactions |
| EDC | 0 Å | Carboxyl-amine | Direct contact sites |
| SMCC | 8.3 Å | Amine-sulfhydryl | Cysteine-specific interactions |
Surface Plasmon Resonance (SPR)
Immobilize purified cbim1 on a sensor chip
Flow potential interacting partners over the surface
Measure binding kinetics and affinity constants
Cryo-electron microscopy
Purify intact transport complexes in detergent micelles or nanodiscs
Determine structure at near-atomic resolution
Map interaction interfaces at the molecular level
X-ray crystallography of subcomplexes
Co-purify and crystallize cbim1 with individual partners
Determine structures of binary complexes
Build composite models of the full transport complex
These approaches provide complementary information about the composition, stoichiometry, and structural arrangement of the cobalt transport complex. Integration of data from multiple methods yields the most comprehensive understanding of the system .
As a membrane protein, cbim1 presents significant challenges related to solubility and aggregation. These issues can be addressed through systematic optimization of expression and purification conditions:
Expression optimization
Reduce expression temperature to 16-18°C
Decrease inducer concentration (0.1-0.2 mM IPTG)
Use specialized E. coli strains (C41/C43) designed for membrane proteins
Consider fusion tags that enhance solubility (MBP, SUMO)
Lysis and extraction conditions
Screen different detergents for optimal extraction:
| Detergent | Critical Micelle Concentration | Suitability for cbim1 |
|---|---|---|
| DDM | 0.17 mM | Excellent primary choice |
| LMNG | 0.01 mM | Good for long-term stability |
| CHAPS | 8-10 mM | Mild, may give lower yield |
| SDS | 8.2 mM | Harsh, may denature protein |
Include stabilizing additives:
Glycerol (10-20%)
Specific lipids (0.01-0.1 mg/mL)
Low concentrations of cobalt (10-50 μM CoCl2)
Buffer optimization
Screen pH range (7.0-8.5)
Test various salt concentrations (100-500 mM NaCl)
Add osmolytes (trehalose, sucrose) at 5-10%
Aggregation removal
Centrifugation at 100,000×g for 30 minutes before chromatography
Filtration through 0.22 μm membrane
Addition of non-ionic detergents at concentrations slightly above CMC
Refolding strategies
Solubilize inclusion bodies in 8M urea or 6M guanidine HCl
Perform stepwise dialysis with decreasing denaturant and increasing detergent
Monitor refolding by CD spectroscopy
Alternative solubilization platforms
Reconstitution into nanodiscs using MSP1D1 scaffold protein
Incorporation into amphipols (A8-35)
Solubilization using SMALPs (styrene-maleic acid lipid particles)
By systematically addressing these variables, researchers can significantly improve the solubility and homogeneity of recombinant cbim1 preparations. Success can be monitored by analytical SEC, DLS, and negative-stain electron microscopy to assess monodispersity .
Functional characterization of cbim1 presents several challenges that can lead to misinterpretation of experimental results. Understanding these pitfalls and implementing appropriate controls is essential:
Pitfall: Many divalent metal-binding assays lack specificity, leading to false positive results.
Solution:
Perform comparative binding studies with multiple divalent metals (Co2+, Ni2+, Zn2+, Fe2+)
Include negative controls using denatured protein or non-relevant membrane proteins
Use competition assays where unlabeled metals compete with labeled cobalt
Employ isothermal titration calorimetry (ITC) to obtain thermodynamic parameters specific to cobalt binding
Pitfall: Variable incorporation of protein into liposomes affects transport assay results.
Solution:
Quantify protein incorporation by SDS-PAGE analysis of reconstituted proteoliposomes
Normalize transport data to actual protein content rather than initial protein amount
Use fluorescent labeling to determine protein orientation in liposomes
Include internal standards to account for batch-to-batch variation
Pitfall: Apparent cobalt uptake may represent binding to the protein rather than transport across the membrane.
Solution:
Include ionophores as controls to distinguish binding from transport
Perform assays at multiple temperatures (4°C vs. 37°C) to differentiate between the two processes
Use membrane-impermeable chelators to scavenge external cobalt
Monitor time-dependent kinetics that are characteristic of transport
Pitfall: Studying cbim1 in isolation may not reflect its behavior in the complete transport complex.
Solution:
Compare activity of cbim1 alone versus reconstituted with partner proteins
Establish minimal functional units by systematic reconstitution of components
Use crosslinking to capture transient interaction states during transport
Develop coupled assays that monitor ATP hydrolysis and cobalt transport simultaneously
By addressing these challenges with appropriate experimental design and controls, researchers can obtain more reliable and interpretable data regarding the functional properties of cbim1 in cobalt transport .
Recombinant cbim1 presents valuable opportunities for structural biology investigations that can elucidate the molecular mechanisms of cobalt transport. Several approaches are particularly promising:
Crystallization optimization
Detergent screening (vapor diffusion method):
Maltoside series (DDM, DM, NM)
Glucoside series (OG, NG)
Facial amphiphiles (facial maltoside derivatives)
Lipidic cubic phase (LCP) crystallization:
Monoolein or monopalmitolein as host lipids
Supplementation with specific lipids (POPE, POPG)
Crystal stabilization with cobalt or substrate analogs
Construct optimization
Create thermostabilized variants through systematic mutagenesis
Remove flexible regions that may impede crystal formation
Engineer fusion proteins with crystallization chaperones (T4 lysozyme, BRIL)
Sample preparation strategies
Reconstitution into nanodiscs with MSP1D1 or MSP1E3D1
Incorporation into amphipols (A8-35) or SMALPs
Formation of antibody complexes to increase particle size
Data collection parameters
Use of Volta phase plate for small membrane proteins
Optimal defocus range for 150-200 kDa complexes: -0.8 to -2.0 μm
Consideration of tilted data collection to address preferred orientation
Combining multiple approaches for comprehensive structural characterization:
Small-angle X-ray scattering (SAXS) for solution structure
NMR spectroscopy for dynamic regions and ligand binding
Electron paramagnetic resonance (EPR) spectroscopy for conformational changes
Molecular dynamics simulations based on experimental structures
Cross-linking mass spectrometry for validating structural models
The integration of these methods can provide unprecedented insights into the structure-function relationships of cbim1, particularly in the context of the complete cobalt transport system. Such structural information forms the foundation for understanding substrate specificity, transport mechanisms, and potential applications in synthetic biology .
Several cutting-edge research directions are emerging in the study of cbim1 regulation and function:
Transcriptional regulation networks:
Characterization of promoter elements controlling cbim1 expression
Identification of transcription factors responding to metal availability
Single-cell analysis of expression variability in microbial populations
Integration with metabolic networks:
Connections between cobalt transport and vitamin B12 biosynthesis
Metabolic flux analysis under varying cobalt availability
Computational modeling of cobalt-dependent metabolic pathways
Super-resolution microscopy:
Localization and clustering of cbim1 in bacterial membranes
Dynamics of transporter assembly and disassembly
Colocalization with other transport and metabolic components
Single-molecule techniques:
FRET-based studies of conformational changes during transport
Optical tweezers to measure forces involved in substrate translocation
High-speed AFM to visualize transporter dynamics in membranes
Engineered transport systems:
Design of cbim1 variants with altered metal specificity
Creation of synthetic operons with tunable expression properties
Development of cobalt-dependent biosensors using modified cbim1
Biotechnological applications:
Engineered microorganisms for enhanced cobalt bioaccumulation
Bioremediation strategies for cobalt-contaminated environments
Microbial production of cobalt-dependent enzymes and vitamins
Comparative genomics:
Analysis of cbim1 homologs across bacterial phyla
Identification of adaptive mutations in metal-binding domains
Reconstruction of evolutionary trajectories of cobalt transport systems
Experimental evolution:
Selection for altered cobalt transport properties under laboratory conditions
Characterization of mutations arising under cobalt limitation or excess
Assessment of fitness effects associated with cbim1 variations
These emerging research directions promise to provide a comprehensive understanding of cbim1 function beyond the current molecular and structural perspectives, integrating it into broader cellular and ecological contexts. Such knowledge will have implications not only for fundamental microbiology but also for applications in biotechnology and biomedicine .